The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to noxious particles or gases. Characterized by airflow limitation that is not fully reversible. It is described by the Global Initiative for Chronic Obstructive Lung Disease as “a preventable and treatable disease. It also involves destruction of the tissue of the lung where oxygen is exchanged. Related Lung Conferences | Respiratory Conferences | Pulmonary Conferences :Ĥ th International Conference on Lung and Respiratory Care August 01-02 2016 Manchester UK, 5th International Conference on Respiratory and Pulmonologist November 17-18, 2016 UAE, 2nd International Conference on Respiratory and Pulmonary Medicine May 09-10, 2016 Chicago, USA, 5th International Conference on Radiology and Imaging September 19-20, 2016 Las Vegas, USA, International Conference on Lung Health- Asthma and COPD, January, 15-17, 2016, Monte-Carlo, Monaco, International Conference on Respiratory Health and Smoking, May 24-26, 2016 London, UK, European Respiratory Society, September 26-30, 2016 Amsterdam, Netherlands, International Conference on Tuberculosis and Respiratory Medicine, December 18-20, 2016 Guilin, China, European Lung Foundation, National Institutes of Health (NIH), American Lung Association, Canadian Lung Association, European Respiratory SocietyĬOPD is a disease that involves inflammation and thickening of the airways. As per the investigation of researchers Lung Cancer Death rates not improved when they are diagnosed and most of the lung cancers have progressed to advanced stages. As per the doctor suggestions there are no symptoms associated with first stage of Lung Cancer. The risk factor of Lung Cancer is mainly smoking and Air Pollution. In the year of 2015, the American Cancer Society handled 221,200 new cases and will be diagnosed under 158,040 deaths due to lung cancer only. Trends of lung Cancer related death mostly Smoking over the past several decades. Lung Cancer currently major leading cause of cancer related deaths in men and women in the world. The conference will include explicit keynote and plenary sessions delivered by the distinguished researchers, scientists and honorary lecturers working in the field of Pulmonary research and Respiratory Care. Lung 2016 will encourage the participation of the eminent Professors, Chest Physicians, Pulmonologist, Respiratory Therapist, Lung Association presidents, Researchers and Scholars, Students in all area of Lung and Respiratory care and will provide an international forum for the dissemination of original research results, new ideas and practical development experiences concentrating on the scientific development. Lung Conference aims at gathering the audience from all the major parts of the World with a goal to enhance the scientific knowledge by exploring the latest advancements in the related conference field area. Conference LLC invites all the participants from all over the world to attend ‘4 th International Conference and Exhibition on Lung and Respiratory Care’ during August 01-02, 2016 Manchester, UK which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.